Table 1.
CTCAE gradea (dyspnea, cough, fever) | PFT declineb | Chest CT parenchymal abnormalities | Infectious analysis | Conclusionc |
---|---|---|---|---|
0 | Non-significant | Absent | – | No ILD |
Present | – | Suspected ILD | ||
Significant | Absent | General | Inconclusive | |
Present | General + consider BAL | ILD | ||
1 or 2 | Non-significant | Absent | General | Airway disease |
Present | General + consider BAL | Suspected ILD | ||
Significant | Absent | General + consider BAL | Suspected ILD | |
Present | General + BAL | ILD | ||
3 or 4 | Non-significant | Absent | General + consider BAL | Inconclusive |
Present | General + BAL | ILD | ||
Significant | Absent | General + BAL | Inconclusive | |
Present | General + BAL | ILD |
CTCAE Common Terminology Criteria for Adverse Events, PFT pulmonary function test, ILD interstitial lung disease, BAL bronchoalveolar lavage, DLCOc diffusion capacity of the lungs for carbon monoxide corrected for hemoglobin
aCTCAE pneumonitis NOT included
bSignificant PFT decline defined as: DLCOc corrected for Hb decline ≥ 2 SD compared to baseline AND/OR FVC decline ≥ 2 SD compared to baseline
cProvided that other possible diagnoses are considered or excluded, such as pulmonary infection, congestive heart failure, pulmonary embolism, carcinomatous lymphangitis or pleuritis, radiation recall pneumonitis, asthma bronchiale, or gastroesophageal reflux